Screener
AbCellera Biologics Inc. ABCL Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
Based on trailing twelve months.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s asset turnover?
- AbCellera Biologics Inc. (ABCL) reported asset turnover of 0× in Q2 2026.
- How has AbCellera Biologics Inc.'s asset turnover changed year-over-year?
- AbCellera Biologics Inc.'s asset turnover increased by 108.5% year-over-year, from 0× to 0×.
- What is the long-term trend for AbCellera Biologics Inc.'s asset turnover?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s asset turnover has grown at a -35.7% compound annual growth rate (CAGR), from 0.3× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about AbCellera Biologics Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude